Clinical Trials Logo

Clinical Trial Summary

This is an experimental, multicenter, non-profit study promoted by the Department of Infectious and Tropical Diseases of the IRCCS (Istituto di Ricerca e Cura a carattere scientifico) Sacro Cuore Don Calabria of Negrar which aims to evaluate the presence of endosymbiont Wolbachia in circulating microfilariae obtained from biological samples of individuals infected with M .perstans and the presence of infection with hybrid Schistosoma species in the population of Schistosoma eggs isolated from biological samples of patients with active schistosomiasis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06311344
Study type Interventional
Source IRCCS Sacro Cuore Don Calabria di Negrar
Contact
Status Recruiting
Phase N/A
Start date April 14, 2021
Completion date March 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05999825 - Sm-p80 Schistosomiasis Challenge Study Phase 2
Active, not recruiting NCT03910972 - Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults Phase 1/Phase 2
Completed NCT05085470 - Repeated Controlled Human Schistosoma Mansoni Infection N/A
Completed NCT02755324 - Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding N/A
Completed NCT01054651 - A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni Phase 3
Completed NCT03893097 - Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children Phase 3
Completed NCT04679831 - Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni Phase 2/Phase 3
Withdrawn NCT02810613 - Leiden University Medical Center Mini Donor Bank N/A
Completed NCT02162875 - Schistosoma Mansoni in Mwanza Region, Tanzania N/A